Absorbable bone-wax substitutes: materials, biological response, and clinical evidence

Background Absorbable bone-wax substitutes are designed to stop bone bleeding without leaving a permanent barrier to repair. They need to remain in place until bleeding is controlled and then clear without harmful tissue reactions. Objective To examine how composition and clearance affect hemostasis, bone repair, and clinical outcomes. Methods We documented a focused narrative search through 23 October 2026. Sources included Europe PMC, cited references, publisher records, and official device documents. The core set contained 37 primary reports. We assessed the methods and limitations of clinical and selected animal reports. We did not perform a meta-analysis. Results The core set included four bench-only reports, 29 animal reports, three randomized clinical reports, and one single-arm clinical report. Soluble polymers, polymer–polysaccharide blends, degradable polymers, and self-setting putties differ in how long they remain at the site and how they clear. Several animal studies found less interference with healing than with conventional wax. This does not necessarily mean that the substitute stimulates bone formation. Clinical findings varied by product and procedure. Historical clinical series and separate safety reports provided context but were not counted as contemporary comparative trials. Conclusion Absorbability may reduce the problems caused by retained material, but it does not alone establish better clinical outcomes. Studies should distinguish initial bleeding control from sustained control, dissolution from clearance, and less inhibition of healing from increased bone formation. Comparative trials need clear dosing, reapplication and rescue criteria, suitable controls, and follow-up for infection and union.

Authors

Institutions

Publication Details

Journal
Frontiers in Bioengineering and Biotechnology
Published
2026-11-16
DOI
https://doi.org/10.3389/fbioe.2026.1969375
Primary Topic
Hemostasis and retained surgical items
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Absorbable bone-wax substitutes: materials, biological response, and clinical evidence

Hong Li, Bin Cai, Fulong Zhong, Tielong Liu et al.
4 links
Frontiers in Bioengineering and Biotechnology
Hemostasis and retained surgical items
article

Absorbable bone-wax substitutes: materials, biological response, and clinical evidence

Hong Li, Bin Cai, Fulong Zhong, Tielong Liu, Qing Zhou, Long Yang, Jiaji Ren
article en

Abstract

Background Absorbable bone-wax substitutes are designed to stop bone bleeding without leaving a permanent barrier to repair. They need to remain in place until bleeding is controlled and then clear without harmful tissue reactions. Objective To examine how composition and clearance affect hemostasis, bone repair, and clinical outcomes. Methods We documented a focused narrative search through 23 October 2026. Sources included Europe PMC, cited references, publisher records, and official device documents. The core set contained 37 primary reports. We assessed the methods and limitations of clinical and selected animal reports. We did not perform a meta-analysis. Results The core set included four bench-only reports, 29 animal reports, three randomized clinical reports, and one single-arm clinical report. Soluble polymers, polymer–polysaccharide blends, degradable polymers, and self-setting putties differ in how long they remain at the site and how they clear. Several animal studies found less interference with healing than with conventional wax. This does not necessarily mean that the substitute stimulates bone formation. Clinical findings varied by product and procedure. Historical clinical series and separate safety reports provided context but were not counted as contemporary comparative trials. Conclusion Absorbability may reduce the problems caused by retained material, but it does not alone establish better clinical outcomes. Studies should distinguish initial bleeding control from sustained control, dissolution from clearance, and less inhibition of healing from increased bone formation. Comparative trials need clear dosing, reapplication and rescue criteria, suitable controls, and follow-up for infection and union.

Frontiers in Bioengineering and BiotechnologyVol. 14
Weifang Medical University (CN), Shanghai Jiao Tong University (CN), Sichuan University (CN), Shanghai Sixth People's Hospital (CN)
Sichuan Province Science and Technology Support Program
Good health and well-being
Hemostasis and retained surgical items
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon